LNP Characterization & Analytical Development Summit

The LNP Characterization & Analytical Development Summit is a premier industry-led forum aimed at advancing lipid nanoparticle (LNP) drug products towards regulatory approval. This summit is designed to provide unparalleled technical insights into overcoming critical challenges in LNP characterization, ensuring product quality, safety, efficacy, and compliance with regulatory standards. The event is particularly relevant now, as there has been a surge in interest and investment in LNP technology for gene and cell therapies. Attendees will have the unique opportunity to leverage robust analytical methods that generate reproducible data, thus ensuring product consistency and accelerating regulatory submissions.Participants will engage with a diverse group of attendees from large pharmaceutical companies, innovative biotech firms, and academic institutions. The summit features expert speakers who are at the forefront of LNP analytical development, providing insights into the latest advancements in analytical strategies for targeted and multivalent LNPs. The agenda includes hours of dedicated networking sessions, deep dive workshops, and interactive discussions, allowing for knowledge sharing and collaboration among industry leaders. Attendees will explore cutting-edge characterization strategies that assess LNP size, morphology, and biodistribution, positioning themselves at the heart of LNP deals and collaborations. This event promises to be an enriching experience for those looking to advance their careers and make impactful connections within the field.